Trifa Adrian P, Bănescu Claudia, Dima Delia, Bojan Anca S, Tevet Mihaela, Moldovan Valeriu G, Vesa Ștefan C, Murat Meilin, Pop Ioan V, Skrypnyk Cristina, Popp Radu A
a Department of Medical Genetics, "Iuliu Hațieganu" University of Medicine and Pharmacy , Cluj-Napoca , Romania.
b Department of Genetics , "Ion Chiricuță" Cancer Institute , Cluj-Napoca , Romania.
Hematology. 2016 Oct;21(9):520-5. doi: 10.1080/10245332.2016.1163889. Epub 2016 Mar 30.
To analyze the relationship between six polymorphisms in genes related to oxidative stress, namely CAT-262 C>T, MnSOD Ala16Val, GPX1 Pro198Leu, GSTM1 and GSTT1 null genotypes, and GSTP1 Ile105Val, and the occurrence of BCR-ABL negative myeloproliferative neoplasms (polycythemia vera, essential thrombocythemia, and primary myelofibrosis).
We genotyped for these polymorphisms 328 patients with a known mutation status for JAK2 V617F, MPL and CALR, and 363 controls, using molecular genetics assays.
The CAT-262 C>T and GPX1 Pro198Leu polymorphisms were seen significantly less frequently, while the GSTP1 IleVal105 polymorphism was seen significantly more frequently in patients with BCR-ABL negative myeloproliferative neoplasms, regardless of the molecular sub-type (e.g. JAK2 V617F or CALR mutated).
Our study provides evidence that variation in genes related to oxidative stress might modulate the risk of developing BCR-ABL negative myeloproliferative neoplasms.
分析与氧化应激相关的6种基因多态性,即CAT - 262 C>T、锰超氧化物歧化酶(MnSOD)Ala16Val、谷胱甘肽过氧化物酶1(GPX1)Pro198Leu、谷胱甘肽S - 转移酶M1(GSTM1)和谷胱甘肽S - 转移酶T1(GSTT1)无效基因型以及谷胱甘肽S - 转移酶P1(GSTP1)Ile105Val与BCR - ABL阴性骨髓增殖性肿瘤(真性红细胞增多症、原发性血小板增多症和原发性骨髓纤维化)发生之间的关系。
我们使用分子遗传学检测方法,对328例已知JAK2 V617F、MPL和CALR突变状态的患者以及363例对照进行了这些多态性的基因分型。
无论分子亚型(如JAK2 V617F或CALR突变)如何,在BCR - ABL阴性骨髓增殖性肿瘤患者中,CAT - 262 C>T和GPX1 Pro198Leu多态性的出现频率显著降低,而GSTP1 IleVal105多态性的出现频率显著升高。
我们的研究提供了证据,表明与氧化应激相关的基因变异可能会调节发生BCR - ABL阴性骨髓增殖性肿瘤的风险。